-
1
-
-
0032896745
-
Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3
-
Booth, B.A., Boes, M., Dake, B.L., and Bar, R.S. (1999). Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3. Am. J. Physiol. 276, E450-454.
-
(1999)
Am. J. Physiol.
, vol.276
-
-
Booth, B.A.1
Boes, M.2
Dake, B.L.3
Bar, R.S.4
-
2
-
-
0030709243
-
Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2
-
Bourgeois, L., Brillard-Bourdet, M., Deperthes, D., Juliano, M.A., Juliano, L., Tremblay, R.R., Dube? J.Y., and Gauthier, F. (1997). Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2. J. Biol. Chem. 272, 29590-29595.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 29590-29595
-
-
Bourgeois, L.1
Brillard-Bourdet, M.2
Deperthes, D.3
Juliano, M.A.4
Juliano, L.5
Tremblay, R.R.6
Dube, J.Y.7
Gauthier, F.8
-
3
-
-
0032559272
-
Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
-
DOI 10.1126/science.279.5350.563
-
Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Hennekens, C.H., and Pollak, M. (1998). Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279, 563-566. (Pubitemid 28067285)
-
(1998)
Science
, vol.279
, Issue.5350
, pp. 563-566
-
-
Chan, J.M.1
Stampfer, M.J.2
Giovannucci, E.3
Gann, P.H.4
Ma, J.5
Wilkinson, P.6
Hennekens, C.H.7
Pollak, M.8
-
4
-
-
0036268435
-
Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology
-
Cloutier, S.M., Chagas, J.R., Mach, J.P., Gygi, C.M., Leisinger, H.J., and Deperthes, D. (2002). Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. Eur. J. Biochem. 269, 2747-2754.
-
(2002)
Eur. J. Biochem.
, vol.269
, pp. 2747-2754
-
-
Cloutier, S.M.1
Chagas, J.R.2
MacH, J.P.3
Gygi, C.M.4
Leisinger, H.J.5
Deperthes, D.6
-
5
-
-
0026753517
-
Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
-
Cohen, P., Graves, H.C., Peehl, D.M., Kamarei, M., Giudice, L.C., and Rosenfeld, R.G. (1992). Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75, 1046-1053.
-
(1992)
J. Clin. Endocrinol. Metab.
, vol.75
, pp. 1046-1053
-
-
Cohen, P.1
Graves, H.C.2
Peehl, D.M.3
Kamarei, M.4
Giudice, L.C.5
Rosenfeld, R.G.6
-
6
-
-
0030926344
-
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker
-
Darson, M.F., Pacelli, A., Roche, P., Rittenhouse, H.G., Wolfert, R.L., Young, C.Y., Klee, G.G., Tindall, D.J., and Bostwick, D.G. (1997). Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 49, 857-862.
-
(1997)
Urology
, vol.49
, pp. 857-862
-
-
Darson, M.F.1
Pacelli, A.2
Roche, P.3
Rittenhouse, H.G.4
Wolfert, R.L.5
Young, C.Y.6
Klee, G.G.7
Tindall, D.J.8
Bostwick, D.G.9
-
7
-
-
0030728733
-
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen
-
Denmeade, S.R., Lou, W., Logren, J., Malm, J., Lilja, H., and Isaacs, J.T. (1997). Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. Cancer Res. 57, 4924-4930.
-
(1997)
Cancer Res.
, vol.57
, pp. 4924-4930
-
-
Denmeade, S.R.1
Lou, W.2
Logren, J.3
Malm, J.4
Lilja, H.5
Isaacs, J.T.6
-
8
-
-
0030458254
-
Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation
-
Deperthes, D., Frenette, G., Brillard-Bourdet, M., Bourgeois, L., Gauthier, F., Tremblay, R.R., and Dube, J.Y. (1996). Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J. Androl. 17, 659-665.
-
(1996)
J. Androl.
, vol.17
, pp. 659-665
-
-
Deperthes, D.1
Frenette, G.2
Brillard-Bourdet, M.3
Bourgeois, L.4
Gauthier, F.5
Tremblay, R.R.6
Dube, J.Y.7
-
9
-
-
17744364495
-
Insulin-like growth factor i is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen
-
Finne, P., Auvinen, A., Koistinen, H., Zhang, W.M., Mataen, L., Rannikko, S., Tammela, T., Seppaa M., Hakama, M., and Stenman, U.H. (2000). Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J. Clin. Endocrinol. Metab. 85, 2744-2747.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 2744-2747
-
-
Finne, P.1
Auvinen, A.2
Koistinen, H.3
Zhang, W.M.4
Mataen, L.5
Rannikko, S.6
Tammela, T.7
Seppaa, M.8
Hakama, M.9
Stenman, U.H.10
-
10
-
-
0030975940
-
Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator
-
Frenette, G., Tremblay, R.R., Lazure, C., and Dube, J.Y. (1997). Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator. Int. J. Cancer 71, 897-899.
-
(1997)
Int. J. Cancer
, vol.71
, pp. 897-899
-
-
Frenette, G.1
Tremblay, R.R.2
Lazure, C.3
Dube, J.Y.4
-
11
-
-
33744951683
-
Novel peptide inhibitors of human kallikrein 2
-
Hekim, C., Leinonen, J., Navaen, A., Koistinen, H., Zhu, L., Koivunen, E., Vasaen, V., and Stenman, U.H. (2006). Novel peptide inhibitors of human kallikrein 2. J. Biol. Chem. 281, 12555-12560.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 12555-12560
-
-
Hekim, C.1
Leinonen, J.2
Navaen, A.3
Koistinen, H.4
Zhu, L.5
Koivunen, E.6
Vasaen, V.7
Stenman, U.H.8
-
12
-
-
68549126809
-
Unraveling insulin-like growth factor binding protein-3 actions in human disease
-
Jogie-Brahim, S., Feldman, D., and Oh, Y. (2009). Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr. Rev. 30, 417-437.
-
(2009)
Endocr. Rev.
, vol.30
, pp. 417-437
-
-
Jogie-Brahim, S.1
Feldman, D.2
Oh, Y.3
-
13
-
-
67650911917
-
Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival
-
Johansson, M., McKay, J.D., Rinaldi, S., Wiklund, F., Adami, H. O., Groberg, H., Kaaks, R., and Stattin, P. (2009). Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival. Prostate 69, 1281-1291.
-
(2009)
Prostate
, vol.69
, pp. 1281-1291
-
-
Johansson, M.1
McKay, J.D.2
Rinaldi, S.3
Wiklund, F.4
Adami, H.O.5
Groberg, H.6
Kaaks, R.7
Stattin, P.8
-
14
-
-
0028297296
-
Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies
-
Koistinen, H., Seppaa M., and Koistinen, R. (1994). Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin. Chem. 40, 531-536.
-
(1994)
Clin. Chem.
, vol.40
, pp. 531-536
-
-
Koistinen, H.1
Seppaa, M.2
Koistinen, R.3
-
15
-
-
0036468849
-
Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3
-
Koistinen, H., Paju, A., Koistinen, R., Finne, P., Logren, J., Wu, P., Seppaa M., and Stenman, U.H. (2002). Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3. Prostate 50, 112-118.
-
(2002)
Prostate
, vol.50
, pp. 112-118
-
-
Koistinen, H.1
Paju, A.2
Koistinen, R.3
Finne, P.4
Logren, J.5
Wu, P.6
Seppaa, M.7
Stenman, U.H.8
-
16
-
-
0031577554
-
Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2
-
DOI 10.1006/bbrc.1997.7333
-
Logren, J., Rajakoski, K., Karp, M., Lundwall, A., and Lilja, H. (1997). Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem. Biophys. Res. Commun. 238, 549-555. (Pubitemid 27464425)
-
(1997)
Biochemical and Biophysical Research Communications
, vol.238
, Issue.2
, pp. 549-555
-
-
Lovgren, J.1
Rajakoski, K.2
Karp, M.3
Lundwall, A.4
Lilja, H.5
-
17
-
-
0033572917
-
Production and activation of recombinant hK2 with propeptide mutations resulting in high expression levels
-
Logren, J., Tian, S., Lundwall, A., Karp, M., and Lilja, H. (1999). Production and activation of recombinant hK2 with propeptide mutations resulting in high expression levels. Eur. J. Biochem. 266, 1050-1055.
-
(1999)
Eur. J. Biochem.
, vol.266
, pp. 1050-1055
-
-
Logren, J.1
Tian, S.2
Lundwall, A.3
Karp, M.4
Lilja, H.5
-
18
-
-
33745490771
-
Insulin-like growth factors and their binding proteins in prostate cancer: Cause or consequence?
-
Meinbach, D.S. and Lokeshwar, B.L. (2006). Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence? Urol. Oncol. 24, 294-306.
-
(2006)
Urol. Oncol.
, vol.24
, pp. 294-306
-
-
Meinbach, D.S.1
Lokeshwar, B.L.2
-
19
-
-
0031983565
-
Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors
-
Mikolajczyk, S.D., Millar, L.S., Kumar, A., and Saedi, M.S. (1998). Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate 34, 44-50.
-
(1998)
Prostate
, vol.34
, pp. 44-50
-
-
Mikolajczyk, S.D.1
Millar, L.S.2
Kumar, A.3
Saedi, M.S.4
-
20
-
-
0032917409
-
Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1
-
Mikolajczyk, S.D., Millar, L.S., Kumar, A., and Saedi, M.S. (1999). Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1. Int. J. Cancer 81, 438-442.
-
(1999)
Int. J. Cancer
, vol.81
, pp. 438-442
-
-
Mikolajczyk, S.D.1
Millar, L.S.2
Kumar, A.3
Saedi, M.S.4
-
21
-
-
50349102480
-
Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2
-
Mize, G.J., Wang, W., and Takayama, T.K. (2008). Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2. Mol. Cancer Res. 6, 1043-1051.
-
(2008)
Mol. Cancer Res.
, vol.6
, pp. 1043-1051
-
-
Mize, G.J.1
Wang, W.2
Takayama, T.K.3
-
22
-
-
0032973466
-
The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3
-
Okabe, E., Kajihara, J., Usami, Y., and Hirano, K. (1999). The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3. FEBS Lett. 447, 87-90.
-
(1999)
FEBS Lett.
, vol.447
, pp. 87-90
-
-
Okabe, E.1
Kajihara, J.2
Usami, Y.3
Hirano, K.4
-
23
-
-
35748961384
-
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells
-
Paju, A., Hotakainen, K., Cao, Y., Laurila, T., Gadaleanu, V., Hemminki, A., Stenman, U.H., and Bjartell, A. (2007). Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells. Eur. Urol. 52, 1670-1679.
-
(2007)
Eur. Urol.
, vol.52
, pp. 1670-1679
-
-
Paju, A.1
Hotakainen, K.2
Cao, Y.3
Laurila, T.4
Gadaleanu, V.5
Hemminki, A.6
Stenman, U.H.7
Bjartell, A.8
-
24
-
-
0030972216
-
Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-b1 on programmed cell death through a p53- and IGF-independent mechanism
-
Rajah, R., Valentinis, B., and Cohen, P. (1997). Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-b1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272, 12181-12188.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 12181-12188
-
-
Rajah, R.1
Valentinis, B.2
Cohen, P.3
-
25
-
-
0034824499
-
Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3
-
Reault, S., Monget, P., Mazerbourg, S., Tremblay, R., Gutman, N., Gauthier, F., and Moreau, T. (2001). Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. Eur. J. Biochem. 268, 2960-2968.
-
(2001)
Eur. J. Biochem.
, vol.268
, pp. 2960-2968
-
-
Reault, S.1
Monget, P.2
Mazerbourg, S.3
Tremblay, R.4
Gutman, N.5
Gauthier, F.6
Moreau, T.7
-
26
-
-
33645868681
-
Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGFdependent and IGF-independent mechanisms
-
Silha, J.V., Sheppard, P.C., Mishra, S., Gui, Y., Schwartz, J., Dodd, J.G., and Murphy, L.J. (2006). Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGFdependent and IGF-independent mechanisms. Endocrinology 147, 2112-2121.
-
(2006)
Endocrinology
, vol.147
, pp. 2112-2121
-
-
Silha, J.V.1
Sheppard, P.C.2
Mishra, S.3
Gui, Y.4
Schwartz, J.5
Dodd, J.G.6
Murphy, L.J.7
-
27
-
-
0026536710
-
Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein
-
Young, C.Y., Andrews, P.E., Montgomery, B.T., and Tindall, D.J. (1992). Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 31, 818-824.
-
(1992)
Biochemistry
, vol.31
, pp. 818-824
-
-
Young, C.Y.1
Andrews, P.E.2
Montgomery, B.T.3
Tindall, D.J.4
|